Onco-Innovations Limited (NEO:ONCO)

Market Cap	99.33M
Revenue (ttm)	84.79K
Net Income (ttm)	-10.83M
Shares Out	54.28M
EPS (ttm)	-0.27
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,300
Average Volume	47,801
Open	1.820
Previous Close	1.850
Day's Range	1.820 - 1.830
52-Week Range	0.560 - 2.800
Beta	n/a
RSI	45.07
Earnings Date	Sep 18, 2025

About Onco-Innovations

Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments. The company’s lead product candidate is ONC010, a novel inhibitor of the DNA repair enzyme a Polynucleotide Kinase 3′-Phosphatase (PNKP) in a nanoparticle formulation based on the drug delivery technology. Onco-Innovations Limited is headquartered in Calgary, Canada.

• Industry: Biological Products, Except Diagnostic Substances
• CEO: Thomas O’Shaughnessy
• Employees: 1
• Stock Exchange: Cboe Canada
• Ticker Symbol: ONCO